Additionally, the destructive properties of subventricular NPCs against GBM cells appeared dependent on the expression of D-type cyclins, in particular cyclin D1 (cD1) and cD2, genes that act as key brain tumor oncogenes [53,54]. The gene discussed is CD2; the disease is glioblastoma.